• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在《WHO 造血和淋巴组织肿瘤分类》第四版修订本中前体淋巴细胞肿瘤病理学的更新。

Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

机构信息

Department of Pathology, University of Virginia, Charlottesville, VA, USA.

Departments of Pathology & Dermatology, University of Virginia, 415 Lane Road, Hospital Expansion Bldg Room 3024, Charlottesville, VA, 22908, USA.

出版信息

Curr Hematol Malig Rep. 2018 Aug;13(4):275-288. doi: 10.1007/s11899-018-0456-8.

DOI:10.1007/s11899-018-0456-8
PMID:29951888
Abstract

PURPOSE OF REVIEW

Acute lymphoblastic leukemias (ALL) are malignant disorders of immature B or T cells that occur characteristically in children, usually under the age of 6 (75%). Approximately 6000 new cases of ALL are diagnosed each year in the USA, 80-85% of which represent B-ALL forms. Most presentations of B-ALL are leukemic, whereas T-ALL presents with a mediastinal mass, with or without leukemic involvement. The revised fourth edition of the World Health Organization (WHO) classification (2017) has introduced some changes in both B and T-ALL. Here, we summarize the categories of lymphoblastic leukemia/lymphomas as defined by the WHO and recent developments in the understanding of this group of hematologic malignancy.

RECENT FINDINGS

Two provisional categories of B-ALL have now been identified including B-ALL, BCR-ABL1-like, and B-ALL with iAMP21. The Philadelphia chromosome-like B-ALL includes forms of the disease that shares the expression profiling of B-ALL with t(9;22) but lack such rearrangement. The second one shows amplification of part of the chromosome 21. Both entities are associated with worse prognosis. Within the T-ALL group, an early precursor T cell form has now been introduced as a provisional category. Such group demonstrates expression of stem cell and myeloid markers in conjunction with the T cell antigens. The current review summarizes the recent updates to the WHO classification.

摘要

目的综述

急性淋巴细胞白血病(ALL)是一种幼稚 B 或 T 细胞的恶性疾病,通常发生在儿童期,年龄通常小于 6 岁(75%)。在美国,每年约有 6000 例 ALL 新发病例,其中 80-85%为 B-ALL 形式。大多数 B-ALL 表现为白血病,而 T-ALL 则表现为纵隔肿块,伴或不伴白血病浸润。世界卫生组织(WHO)修订的第四版分类(2017 年)在 B 和 T-ALL 中都引入了一些变化。在这里,我们总结了 WHO 定义的淋巴母细胞白血病/淋巴瘤的类别,以及对这组血液恶性肿瘤的理解的最新进展。

最新发现

现在已经确定了两种暂定的 B-ALL 类别,包括 B-ALL、BCR-ABL1 样和伴有 iAMP21 的 B-ALL。费城染色体样 B-ALL 包括与 t(9;22)具有相同表达谱但缺乏这种重排的疾病形式。第二种情况显示部分 21 号染色体的扩增。这两种实体都与预后较差有关。在 T-ALL 组中,现在已经引入了一种早期前体细胞 T 细胞形式作为暂定类别。该组表现出干细胞和髓系标志物的表达,同时伴有 T 细胞抗原。本综述总结了 WHO 分类的最新更新。

相似文献

1
Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.在《WHO 造血和淋巴组织肿瘤分类》第四版修订本中前体淋巴细胞肿瘤病理学的更新。
Curr Hematol Malig Rep. 2018 Aug;13(4):275-288. doi: 10.1007/s11899-018-0456-8.
2
Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.急性淋巴细胞白血病的新兴分子亚型和治疗方法。
Semin Diagn Pathol. 2023 May;40(3):202-215. doi: 10.1053/j.semdp.2023.04.003. Epub 2023 Apr 9.
3
Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma.BCR-ABL1 样(费城样)B 淋母白血病/淋巴瘤的实验室检测。
Am J Hematol. 2018 Jul;93(7):971-977. doi: 10.1002/ajh.25126. Epub 2018 May 15.
4
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.JAK2抑制剂AG490主要消除具有11q23易位或费城染色体的人类B前体白血病细胞的生长。
Leukemia. 2001 Nov;15(11):1758-68. doi: 10.1038/sj.leu.2402260.
5
Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.将原发性人类费城染色体阳性B细胞急性淋巴细胞白血病细胞重编程为非白血病巨噬细胞。
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4074-9. doi: 10.1073/pnas.1413383112. Epub 2015 Mar 16.
6
[Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].[儿童高危急性淋巴细胞白血病的治疗策略]
Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Apr 18;45(2):327-32.
7
Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell.证据表明,BCR/ABL1 阳性 T 细胞急性淋巴细胞白血病起源于早期淋巴祖细胞。
Pediatr Blood Cancer. 2019 Sep;66(9):e27829. doi: 10.1002/pbc.27829. Epub 2019 May 28.
8
Philadelphia chromosome positive acute B-lymphoblastic leukemia with extreme leukocytosis.费城染色体阳性急性B淋巴细胞白血病伴极度白细胞增多症。
Blood. 2013 Aug 15;122(7):1104. doi: 10.1182/blood-2013-03-490698.
9
International Consensus Classification of acute lymphoblastic leukemia/lymphoma.国际急性淋巴细胞白血病/淋巴瘤分类共识。
Virchows Arch. 2023 Jan;482(1):11-26. doi: 10.1007/s00428-022-03448-8. Epub 2022 Nov 24.
10
Aberrations of chromosomes 9 and 22 in acute lymphoblastic leukemia cases detected by ES-fluorescence in situ hybridization.通过ES-荧光原位杂交检测急性淋巴细胞白血病病例中9号和22号染色体的畸变。
Genet Test Mol Biomarkers. 2012 May;16(5):318-23. doi: 10.1089/gtmb.2011.0186. Epub 2012 Feb 23.

引用本文的文献

1
Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib.用于多发性骨髓瘤的蛋白酶体和PARP1双靶点抑制剂:氟唑帕利。
Biochem Biophys Rep. 2024 Jul 7;39:101781. doi: 10.1016/j.bbrep.2024.101781. eCollection 2024 Sep.
2
CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis.CCR9过表达通过增强胆固醇生物合成促进T细胞急性淋巴细胞白血病进展。
Front Pharmacol. 2023 Sep 6;14:1257289. doi: 10.3389/fphar.2023.1257289. eCollection 2023.
3
Inserting EF1α-driven CD7-specific CAR at CD7 locus reduces fratricide and enhances tumor rejection.

本文引用的文献

1
Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers.与年轻人相比,40 岁以上的前体 T 细胞淋巴母细胞淋巴瘤患者具有不同的预后因素。
Sci Rep. 2018 Jan 18;8(1):1088. doi: 10.1038/s41598-018-19565-x.
2
Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia.T 细胞急性淋巴细胞白血病融合基因的鉴定及转录组特征分析。
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):373-378. doi: 10.1073/pnas.1717125115. Epub 2017 Dec 26.
3
Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
在 CD7 基因座插入 EF1α 驱动的 CD7 特异性 CAR 可减少自相残杀并增强肿瘤排斥。
Leukemia. 2023 Aug;37(8):1660-1670. doi: 10.1038/s41375-023-01948-3. Epub 2023 Jun 30.
4
Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.靶向白血病、骨髓增生异常综合征和淋巴瘤中的 DNA 甲基化:一种有潜在诊断、预后和治疗价值的工具。
Int J Mol Sci. 2022 Dec 30;24(1):633. doi: 10.3390/ijms24010633.
5
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.内消蛋白在急性白血病中的作用:现状与展望。
Biomolecules. 2022 Mar 24;12(4):492. doi: 10.3390/biom12040492.
6
Prognostic Significance of Comprehensive Gene Mutations and Clinical Characteristics in Adult T-Cell Acute Lymphoblastic Leukemia Based on Next-Generation Sequencing.基于二代测序的成人T细胞急性淋巴细胞白血病综合基因突变及临床特征的预后意义
Front Oncol. 2022 Feb 24;12:811151. doi: 10.3389/fonc.2022.811151. eCollection 2022.
7
Mature B cell acute lymphoblastic leukaemia with KMT2A-MLLT3 transcripts in children: three case reports and literature reviews.儿童伴 KMT2A-MLLT3 转录本的成熟 B 细胞急性淋巴细胞白血病:三例病例报告及文献复习。
Orphanet J Rare Dis. 2021 Jul 30;16(1):331. doi: 10.1186/s13023-021-01972-5.
8
Diagnostic Utility of SOX4 Expression in Adult T-Cell Leukemia/Lymphoma.SOX4表达在成人T细胞白血病/淋巴瘤中的诊断效用
Diagnostics (Basel). 2021 Apr 24;11(5):766. doi: 10.3390/diagnostics11050766.
9
[The pathological diagnosis and differential diagnosis of hematopoietic cell tumors of ambiguous lineage].[谱系不明确的造血细胞肿瘤的病理诊断与鉴别诊断]
Zhonghua Xue Ye Xue Za Zhi. 2021 Mar 14;42(3):238-242. doi: 10.3760/cma.j.issn.0253-2727.2021.03.010.
10
Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.T 细胞急性淋巴细胞白血病免疫治疗的现状与挑战
Int J Mol Sci. 2020 Oct 16;21(20):7685. doi: 10.3390/ijms21207685.
利用新型原 T 细胞模型系统定义 TAL1 表达与 Pten 缺失在 T-ALL 中致癌协同作用的分子基础。
Leukemia. 2018 Apr;32(4):941-951. doi: 10.1038/leu.2017.328. Epub 2017 Nov 20.
4
B Lymphoblastic Leukemia Minimal Residual Disease Assessment by Flow Cytometric Analysis.通过流式细胞术分析评估B淋巴细胞白血病微小残留病
Clin Lab Med. 2017 Dec;37(4):771-785. doi: 10.1016/j.cll.2017.07.005. Epub 2017 Aug 31.
5
B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients.成人伴伯基特样形态学和 IGH/MYC 重排的 B 淋巴母细胞白血病/淋巴瘤:3 例报告。
Am J Surg Pathol. 2018 Feb;42(2):269-276. doi: 10.1097/PAS.0000000000000982.
6
Philadelphia chromosome-like acute lymphoblastic leukemia.费城染色体样急性淋巴细胞白血病
Blood. 2017 Nov 9;130(19):2064-2072. doi: 10.1182/blood-2017-06-743252. Epub 2017 Oct 2.
7
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.Ph 阴性 B 细胞前体急性淋巴细胞白血病成人患者细胞遗传学异常的影响。
Blood. 2017 Oct 19;130(16):1832-1844. doi: 10.1182/blood-2017-05-783852. Epub 2017 Aug 8.
8
BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside.BCR-ABL1样急性淋巴细胞白血病:从实验室到临床
Eur J Cancer. 2017 Sep;82:203-218. doi: 10.1016/j.ejca.2017.06.012. Epub 2017 Jul 12.
9
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.儿童及青年T细胞系急性淋巴细胞白血病的基因组图谱
Nat Genet. 2017 Aug;49(8):1211-1218. doi: 10.1038/ng.3909. Epub 2017 Jul 3.
10
Acute lymphoblastic leukemia: a comprehensive review and 2017 update.急性淋巴细胞白血病:全面综述及2017年更新
Blood Cancer J. 2017 Jun 30;7(6):e577. doi: 10.1038/bcj.2017.53.